Loading people...
Dan Galles is a Partner at Allumia Ventures, formerly Providence Ventures, based in the San Francisco Bay Area. He brings over 20 years of healthcare investment experience to the firm, which recently spun out from the Providence healthcare system to raise a $150 million third fund. Prior to his current role, Galles served as a Partner at HLM Venture Partners, where he led or co-led investments in 14 companies, and worked as an associate at J.H. Whitney and Co. His portfolio oversight includes board and observer roles at more than 13 companies, featuring successful exits such as Gauss Surgical to Stryker, Twistle to Health Catalyst, and the initial public offering of One Medical. Holding degrees from the Wharton School and Northwestern University, Galles focuses his investments on early- and growth-stage healthcare information technology, services, and medical device startups.
Dan Galles is a distinguished Venture Capitalist at Providence Ventures, the strategic venture capital arm of Providence Health & Services. In his role, Dan is instrumental in sourcing, evaluating, and investing in innovative companies that are poised to revolutionize the healthcare landscape. Providence Ventures leverages the vast clinical expertise and operational insights of one of the nation's largest health systems, and Dan's work directly contributes to advancing its mission of health for a better world.
Dan's investment focus areas are broad yet deeply specialized, reflecting the evolving needs of modern healthcare. He actively seeks out early to growth-stage companies developing cutting-edge solutions in digital health, artificial intelligence and machine learning applications in healthcare, personalized medicine, value-based care models, and patient engagement platforms. His portfolio interests also extend to health IT infrastructure, medical devices, and solutions that improve clinical workflows and operational efficiencies for providers and patients alike. Dan is particularly keen on technologies that demonstrate clear potential for scalability, strong clinical validation, and a tangible impact on patient outcomes and cost reduction.
Before joining Providence Ventures, Dan built a robust career foundation that equipped him with a unique perspective on healthcare innovation and investment. His background often includes experience in corporate development, strategic consulting, or prior roles within the venture capital or private equity sectors, frequently with a focus on technology or life sciences. This diverse experience allows him to not only identify promising startups but also to provide invaluable strategic guidance and operational support to portfolio companies, helping them navigate the complex healthcare market and accelerate their growth.
While specific public details of all his notable investments are proprietary, Dan Galles has a track record of championing companies that have gone on to achieve significant milestones. His portfolio contributions include firms that have successfully developed and scaled solutions for remote patient monitoring, AI-powered diagnostic tools, and platforms enhancing provider-patient communication. These investments underscore his commitment to fostering innovation that directly addresses critical challenges in healthcare delivery and access. Dan's strategic vision and deep industry knowledge make him a key player in shaping the future of healthcare through venture capital.
Dan Galles is a Venture Capitalist at Providence Ventures, specializing in strategic investments in healthcare technology and service companies.
He invests in early to growth-stage healthcare technology companies, focusing on digital health, AI/ML in healthcare, personalized medicine, value-based care, and patient engagement solutions.
Dan Galles works at Providence Ventures, the venture capital arm of Providence Health & Services.
